我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

基质金属蛋白酶与冠脉再狭窄(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2005年第1期
页码:
77-80
栏目:
综述
出版日期:
2005-01-05

文章信息/Info

Title:
-
作者:
顾俊 综述; 王长谦 审校
上海第二医科大学附属仁济医院心内科， 上海 200001
Author(s):
-
关键词:
基质金属蛋白酶; 冠脉再狭窄; 血管重构; 整合素
Keywords:
-
分类号:
R541.4
DOI:
-
文献标识码:
A
摘要:
冠心病患者行经皮冠状动脉腔内成形术（PTCA）后，冠脉再狭窄率居高不下已成为该病治疗过程中最受关注的焦点。随着这方面工作的大力开展，对冠脉再狭窄机制的了解逐渐深入，其中基质金属蛋白酶（MMPs）发挥着相当重要的作用，它不仅促进中膜平滑肌细胞激活、迁移、内膜增生，还与血小板激活过程、血管各层重构有关，本文作者对此作一综述。
Abstract:
-

参考文献/References

［1］ 田建伟，赵连友，郑强荪. PTCA术后再狭窄机制的研究现状［J］. 心脏杂志，2002，14（4）：353-358.

［2］ Creemers EE,Cleutjens JP,Smits JF, et al. Matrix metalloproteinases inhibitor after myocardial infarction: a new approach to present heart failure［J］. Circ Res,2001,89(3):201-210.

［3］ Etoh T,Joffs C,Deschamps AI,et al. Mycardial and interstitial matrix metalloproteinase activity after acute mycardiol infarction in pigs ［J］. Am J Physiol Heart Circ Physiol,2001,281(3):H987-H994.

［4］ Galt SW,Lindemann S,Allen L, et al. Outsidein signals delivered by matrix metalloproteinase1 regulate platelet funtion［J］. Circ Res,2002,90(10):1093-1099.

［5］ Dumin JA,Dickeson SK,Stricker TP, et al. Procollagenase (matrix metalloproteinase1) binds the α2β1 integrin upon release from keratinocytes migrating on type Ⅰ collagen［J］ . J Biol Chem,2001,276(31):29368-29374.

［6］ Stricker TP,Dumin JA,Dickeson SK,et al. Structural analysis of the α2 integrin Ⅰdomain/procollagenase1(matrix metallproteinase1)interaction［J］. J Biol Chem, 2001,276(31):29375-29381.

［7］ Hojo Y,Ikeda U,Katsuki TA,et al. Matrix metalloproteinase expression in the coronary circulation individual by coronary angioplasty［J］. Atherosclerosis,2002,161(1):185-192.

［8］ Cho A,Reidy MA.Matrix metalloproteinase9 is necessary for the regulation of smooth muscle cell replication and migration after artery injury［J］. Circ Res,2002,91(9):845-851.

［9］ Bendeck MP,Irvin C,Reidy M,et al. Smooth muscle cell matrix metalloproteinase prodution is stimulated via αvβ3 integrin［J］. Arterioscler Thromb Vasc Biol,2000,20(6):1467-1472.

［10］Sajid M,Zhao R,Pathak A,et al. Alphavbeta3integrin antagonists inhibit thrombin induced proliferation and focal adhesion formation in smooth muscel cells［J］. Am J Physiol Cell Physiol, 2003,285(5):C1330-C1338.

［11］Margolin L,Fishbein I,Banai S,et al. Metalloproteinase inhibitor attenuates neointima formation and constructure remolding after angioplasty in rats:augmemtative effect of αvβ3 receptor blockade［J］. Atherosclerosis,2002,163(2):269-277.

［12］Hofmann UB,Westphal JR,Van kraats AA,et al. Expression of integrin alphav beta3 correlates with activation of membranetype matrix metalloproteinase1(MTMMP) and matrix metalloproteinase2(MMP2) in human melanoma cells in vitro and vivo［J］. Int J Cancer, 2000,87(1):12-19.

［13］Blindt R,Bosserhoff AK,Krott N,et al. Decrease of vascular smooth muscel cell locomotion by abciximab but not tirofin,a positive role of different affinity to alphav beta3 integrin［J］. Coronary Artery Disease,2002,13(7):357-364.

［14］Sierevogel MJ,Velema E,Van der meer FJ, et al. Matrix metallpoprteinase inhibitor reduces adeventitial thicking and collagen accumulation following dilation［J］. Cardiovasc Res, 2002,55(4):864-869.

［15］Cho HJ,Chae IH,Park KW,et al. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis after percutaneous coronary intervention［J］. J Hum Genet,2002,47(2):88-91.

［16］Humphries S,Bauters C,Meihaeghe A,et al. The 5A6A polymorphism in the promoter of the stromelysin1(MMP3)gene as a risk factor for restenosis［J］. Eur Heart J,2002,23(9):721-725.

［17］Masuda T,Nakayama Y.Development of a watersoluble matrix metallopreinase inhibitor as an intraarterial infusion drug for prevention of restenosis after angioplasty［J］. J Med Chem, 2003,46(16):3497-3501.

［18］张斌，韦方，耿庆山，等. 辛伐他汀对动脉粥样硬化斑块中MMPs及TIMPs表达的影响［J］. 心脏杂志，2003，15（6）：513-515.

备注/Memo

备注/Memo:
收稿日期：2004-03-01.
更新日期/Last Update: 2010-01-05